CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 


SCHERING-PLOUGH CORPORATION  (SGP)
Other Ticker:  
 
    Sector  Consumer Non Cyclical    Industry Legacy
 
   Industry Legacy
   Sector  Consumer Non Cyclical

Schering-plough's

Competitiveness


 

SGP Sales vs. its Competitors Q3 2009



Comparing the results to its competitors, Schering-plough reported Total Revenue decrease in the 3 quarter 2009 year on year by -1.68 %, faster than overall decrease of Schering-plough's competitors by -1.86 %, recorded in the same quarter.

List of SGP Competitors

With net margin of 11.45 % company reported lower profitability than its competitors.

More on SGP Margin Comparisons


   
       
 
You need to upgrade your Flash Player
   
     
       
 
You need to upgrade your Flash Player
   
     
       
 
You need to upgrade your Flash Player
   
     
       
 
You need to upgrade your Flash Player
   
     
       
 
You need to upgrade your Flash Player
   
     
       
 

Net Income Comparison


SCHERING-PLOUGH CORPORATION Net Income in 3 quarter 2009 declined year on year by -12.56 %, despite income growth by most of its competitors

<<  More on SGP Income Comparisons
   
     



<<  See the full list of SGP competitors


Competitiveness By Company's Divisions



  

Animal Health Care Segment Market Share Q3 2009

despite revenue deterioration, Schering-plough inceased its market share in this segment.

company inceased its market share in this segment to approximate 36.29 %.



<<  More on SGP Market Share.
You need to upgrade your Flash Player
 

  

Clarinex/Aerius Segment Market Share Q3 2009

Clarinex/Aerius segment, revenue fell by -40.91 % and company lost market share, to approximate 5.03 %.





<<  More on SGP Market Share.
You need to upgrade your Flash Player
 

  

Consumer Health Care Segment Market Share Q3 2009

With modest revenue growth of 1.44 % within Consumer Health Care segment, SCHERING-PLOUGH CORPORATION managed to improve its market share within this segment to approximate 3.69 %.

<<  More on SGP Market Share.
You need to upgrade your Flash Player
 

  

Integrilin Segment Market Share Q3 2009

Integrilin segment, revenue fell by -94.05 % and company lost market share, to approximate 0.03 %.





<<  More on SGP Market Share.
You need to upgrade your Flash Player
 

  

PEG-Intron Segment Market Share Q3 2009

PEG-Intron segment, revenue fell by -27.66 % and company lost market share, to approximate 5.68 %.





<<  More on SGP Market Share.
You need to upgrade your Flash Player
 

  

Rebetol Segment Market Share Q3 2009

Rebetol segment revenue, grew with moderate pace of 1.59 % slower than competitors within this segment.

<<  More on SGP Market Share.
You need to upgrade your Flash Player
 

  

Remicade Segment Market Share Q3 2009

Revenue in Remicade segment grew by 7.8 %, less than SCHERING-PLOUGH CORPORATION peers within this segment.

<<  More on SGP Market Share.
You need to upgrade your Flash Player
 

  

Temodar Segment Market Share Q3 2009

Temodar segment, revenue fell by -34.8 % and company lost market share, to approximate 0.91 %.





<<  More on SGP Market Share.
You need to upgrade your Flash Player
 


You need to upgrade your Flash Player


SGP's vs. Competition, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME TICKER MARKET CAP REVENUES INCOME EMPLOYEES
SCHERING-PLOUGH CORPORATION SGP 0 0 0 -
Abbott Laboratories ABT 107,152 28,445 476 77,000
King Pharmaceuticals, Inc. KG 0 0 0 0
Pfizer Inc PFE 219,566 52,927 20,730 78,300
MEDIMMUNE, INC. MEDI 0 0 0 0
Merck & Co., Inc. MRK 165,941 40,725 1,603 70,000
Allergan Plc AGN 57,103 16,040 -1,839 10,500
Biogen Inc. BIIB 61,448 12,594 3,094 7,550
Wyeth WYE 0 0 0 0
Amgen Inc. AMGN 131,222 22,939 2,219 17,900
COVIDIEN LTD. COV 0 0 0 39,500
Bristol Myers Squibb Co BMY 89,095 21,040 944 25,000
Lilly Eli & Co LLY 89,842 23,343 1,124 39,135
HOSPIRA, INC. HSP 0 0 0 0
Johnson & Johnson JNJ 333,947 78,693 1,245 126,500
Watson Pharmaceuticals Inc WPI 0 0 0 0
Actavis Plc ACT 0 0 0 19,200
Mylan N.v. MYL 19,649 11,535 903 25,000
Procter & Gamble Co PG 209,698 65,058 15,411 110,000
GENZYME CORPORATION. GENZ 0 0 0 0
FOREST LABORATORIES, INC. FRX 0 0 0 0
Cephalon, Inc. CEPH 0 0 0 0
Celgene Corp CELG 60,020 13,576 -95 6,012
Zivo Bioscience, Inc. ZIVO 23 0 -12 2
Balchem Corp BCPC 3,154 618 94 1,060
Patterson Companies, Inc. PDCO 2,231 5,510 242 7,000
SUBTOTAL 1,550,091 393,044 46,139 659,659
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

KIRK's Profile

Stock Price

KIRK's Financials

Business Description

Fundamentals

Charts & Quotes

KIRK's News

Suppliers

KIRK's Competitors

Customers & Markets

Economic Indicators

KIRK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071